Burch R.C. Buse D.C. Lipton R.B.

Migraine: Epidemiology, Burden, and Comorbidity.

Neurol Clin. 37: 631-649

Pediatric Migraine.

Neurol Clin. 27: 481-501Vos T. Abajobir A.A. Abbafati C. et al.

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016.

Lancet. 390: 1211-1259Steiner T.J. Stovner L.J. Vos T. et al.

Migraine is first cause of disability in under 50s: will health politicians now take notice?.

J Headache Pain. https://doi.org/10.1186/s10194-018-0846-2Allain-Regnault M. Bwibo N.O. Chigier E.

Young people’s health - A challenge for society.

World Heal Organ - Tech Rep Ser. 731: 1-117Hershey A.D. Powers S.W. Vockell A.L.B. et al.

Development of a patient-based grading scale for PedMIDAS.

Cephalalgia. 24: 844-849

New daily persistent headache: A systematic review on an enigmatic disorder.

J Headache Pain. https://doi.org/10.1186/s10194-019-1022-z

New daily persistent headache (NDPH) triggered by a single Valsalva event: A case series.

Cephalalgia. 39: 785-791

New Daily Persistent Headache Is Most Likely to Begin at the Start of School.

J Child Neurol. 31: 864-868Strong E. Pierce E.L. Langdon R. et al.

New Daily Persistent Headache in a Pediatric Population.

J Child Neurol. 36: 888-893Ghosh A. Silva E. Burish M.J.

Pediatric-onset trigeminal autonomic cephalalgias: A systematic review and meta-analysis.

Cephalalgia. 41: 1382-1395Oskoui M. Pringsheim T. Holler-Managan Y. et al.

Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.

Neurology. 93: 487-499

Short-term treatment of Migraine in Children and Adolescents.

JAMA. 174: 789-790Hämäläinen M.L. Hoppu K. Valkeila E. et al.

Ibuprofen or acetaminophen for the acute treatment of migraine in children: A double-blind, randomized, placebo-controlled, crossover study.

Neurology. 48: 103-107Lipton R.B. Munjal S. Brand-Schieber E. et al.

Efficacy, Tolerability, and Safety of DFN-15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study.

Headache. 60: 58-70Cady R. Nett R. Dexter K. et al.

Treatment of chronic migraine: A 3-month comparator study of naproxen sodium vs SumaRT/Nap.

Headache. 54: 80-93Ferrari M.D. Roon K.I. Lipton R.B. et al.

Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: A meta-analysis of 53 trials.

Lancet. 358: 1668-1675Kabbouche M.A. Vockell A.L. LeCates S.L. et al.

Tolerability and effectiveness of prochlorperazine for intractable migraine in children.

Pediatrics. 107https://doi.org/10.1542/peds.107.4.e62Trottier E.D. Bailey B. Lucas N. et al.

Prochlorperazine in children with migraine: A look at its effectiveness and rate of akathisia.

Am J Emerg Med. 30: 456-463Brousseau D.C. Duffy S.J. Anderson A.C. et al.

Treatment of Pediatric Migraine Headaches: A Randomized, Double-Blind Trial of Prochlorperazine Versus Ketorolac.

Ann Emerg Med. 43: 256-262Trottier E.D. Bailey B. Dauphin-Pierre S. et al.

Clinical outcomes of children treated with intravenous prochlorperazine for migraine in a pediatric emergency department.

J Emerg Med. 39: 166-173

Chlorpromazine for the treatment of migraine in a pediatric emergency department.

Headache. 54: 335-342Hodgson S.E. Harding A.M. Bourke E.M. et al.

A prospective, randomized, double-blind trial of intravenous chlorpromazine versus intravenous prochlorperazine for the treatment of acute migraine in adults presenting to the emergency department.

Headache. 61: 603-611Marmura M.J. Silberstein S.D. Schwedt T.J.

The acute treatment of migraine in adults: The american headache society evidence assessment of migraine pharmacotherapies.

Headache. 55: 3-20

Intramuscular prochlorperazine versus metoclopramide as single-agent therapy for the treatment of acute migraine headache.

Am J Emerg Med. 14: 262-264Friedman B.W. Esses D. Solorzano C. et al.

A Randomized Controlled Trial of Prochlorperazine Versus Metoclopramide for Treatment of Acute Migraine.

Ann Emerg Med. 52: 399-406Goadsby P.J. Wietecha L.A. Dennehy E.B. et al.

Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine.

Brain. 142: 1894-1904Croop R. Goadsby P.J. Stock D.A. et al.

Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial.

Lancet. 394: 737-745Dodick D.W. Lipton R.B. Ailani J. et al.

Ubrogepant for the Treatment of Migraine.

N Engl J Med. 381: 2230-2241Paruthi S. Brooks L.J. D’Ambrosio C. et al.

Consensus Statement of the American Academy of Sleep Medicine on the Recommended Amount of Sleep for Healthy Children: Methodology and Discussion.

J Clin Sleep Med. 12: 1549-1561

Developmental changes in sleep biology and potential effects on adolescent behavior and caffeine use.

Nutr Rev. 72: 60-64Hysing M. Pallesen S. Stormark K.M. et al.

Sleep and use of electronic devices in adolescence: Results from a large population-based study.

BMJ Open. 5: 1-7Cajochen C. Frey S. Anders D. et al.

Evening exposure to a light-emitting diodes (LED)-backlit computer screen affects circadian physiology and cognitive performance.

J Appl Physiol. 110: 1432-1438Howatson G. Bell P.G. Tallent J. et al.

Effect of tart cherry juice (Prunus cerasus) on melatonin levels and enhanced sleep quality.

Eur J Nutr. 51: 909-916Bektaş Ö. Uʇur C. Gençtürk Z.B. et al.

Relationship of childhood headaches with preferences in leisure time activities, depression, anxiety and eating habits: A population-based, cross-sectional study.

Cephalalgia. 35: 527-537Peris F. Donoghue S. Torres F. et al.

Towards improved migraine management: Determining potential trigger factors in individual patients.

Cephalalgia. 37: 452-463Gelfand Amy A. Pavitt Sara Greene Kaitlin et al.

High School Start Time and Migraine Frequency in High School Students.

Headache. 59: 1024-1031Goadsby P.J. Holland P.R. Martins-Oliveira M. et al.

Pathophysiology of Migraine: A Disorder of Sensory Processing.

Physiol Rev. 97: 553-622Cuvellier J.C. Mars A. Vallée L.

The prevalence of premonitory symptoms in paediatric migraine: A questionnaire study in 103 children and adolescents.

Cephalalgia. 29: 1197-1201Karsan N. Bose P. Goadsby P.J.

The Migraine Premonitory Phase.

Contin Lifelong Learn Neurol. 24: 996-1008Arca K.N. Halker Singh R.B.

Dehydration and Headache.

Curr Pain Headache Rep. 25: 4-9Perry B.G. Bear T.L.K. Lucas S.J.E. et al.

Mild dehydration modifies the cerebrovascular response to the cold pressor test.

Exp Physiol. 101: 135-142Kenney E.L. Long M.W. Cradock A.L. et al.

Prevalence of inadequate hydration among US children and disparities by gender and race/ethnicity: National Health and Nutrition Examination Survey, 2009-2012.

Am J Public Health. 105: e113-e118Spigt M. Weerkamp N. Troost J. et al.

A randomized trial on the effects of regular water intake in patients with recurrent headaches.

Fam Pract. 29: 370-375Khorsha F. Mirzababaei A. Togha M. et al.

Association of drinking water and migraine headache severity.

J Clin Neurosci. 77: 81-84

Medicine I of. Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate.; 2005. doi:10.17226/10925.

Amin F.M. Aristeidou S. Baraldi C. et al.

The association between migraine and physical exercise.

J Headache Pain. 19: 83Robberstad L. Dyb G. Hagen K. et al.

An unfavorable lifestyle and recurrent headaches among adolescents: The HUNT Study.

Neurology. 75: 712-717Bigal M.E. Liberman J.N. Lipton R.B.

Obesity and migraine: A population study.

Neurology. 66: 545-550Varkey E. Cider Å. Carlsson J. et al.

Exercise as migraine prophylaxis: A randomized study using relaxation and topiramate as controls.

Cephalalgia. 31: 1428-1438Santiago M.D.S. Carvalho D. de S. Gabbai A.A. et al.

Amitriptyline and aerobic exercise or amitriptyline alone in the treatment of chronic migraine: A randomized comparative study.

Arq Neuropsiquiatr. 72: 851-855Oskoui M. Pringsheim T. Billinghurst L. et al.

Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention.

Neurology. https://doi.org/10.1212/wnl.0000000000008105Powers S.W. Coffey C.S. Chamberlin L.A. et al.

Trial of amitriptyline, topiramate, and placebo for pediatric migraine.

N Engl J Med. https://doi.org/10.1056/NEJMoa1610384

Retrospective Observational Study on Riboflavin Prophylaxis in Child and Adolescent Migraine.

Pediatr Neurol. 114https://doi.org/10.1016/j.pediatrneurol.2020.09.009Ebrahimi-Monfared M. Sharafkhah M. Abdolrazaghnejad A. et al.

Use of melatonin versus valproic acid in prophylaxis of migraine patients: A double-blind randomized clinical trial.

Restor Neurol Neurosci. 35: 385-393Gonçalves A.L. Ferreira A.M. Ribeiro R.T. et al.

Research paper: Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention.

J Neurol Neurosurg Psychiatry. 87: 1127Sazali S. Badrin S. Norhayati M.N. et al.

Coenzyme Q10 supplementation for prophylaxis in adult patients with migraine-a meta-analysis.

BMJ Open. 11https://doi.org/10.1136/BMJOPEN-2020-039358von Luckner A. Riederer F.

Magnesium in Migraine Prophylaxis—Is There an Evidence-Based Rationale? A Systematic Review.

Headache J Head Face Pain. 58: 199-209Szperka C.L. VanderPluym J. Orr S.L. et al.

Recommendations on the Use of Anti-CGRP Monoclonal Antibodies in Children and Adolescents.

Headache. 58https://doi.org/10.1111/head.13414Greene K.A. Gentile C.P. Szperka C.L. et al.

CGRP Monoclonal Antibody use for the Preventive Treatment of Refractory Headache Disorders in Adolescents.

Pediatr Neurol. 114: 62Hershey A.D. Lin T. Gruper Y. et al.

Remote electrical neuromodulation for acute treatment of migraine in adolescents.

Headache. 61: 310-317Chou D.E. Shnayderman Yugrakh M. Winegarner D. et al.

Acute migraine therapy with external trigeminal neurostimulation (ACME): A randomized controlled trial.

Cephalalgia. 39: 3-14Grazzi L. Egeo G. Liebler E. et al.

No Title.

Neurol Sci. 38: S197-S199Irwin S.L. Qubty W. Allen I.E. et al.

Transcranial Magnetic Stimulation for Migraine Prevention in Adolescents: A Pilot Open-Label Study.

Headache. 58: 724-731Yarnitsky D. Volokh L. Ironi A. et al.

Nonpainful remote electrical stimulation alleviates episodic migraine pain.

Neurology. 88: 1250-1255Ailani J. Burch R.C. Robbins M.S.

The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice.

Headache. 61: 1021-1039Ernst M.M. O’Brien H.L. Powers S.W.

Cognitive-behavioral therapy: How medical providers can increase patient and family openness and access to evidence-based multimodal therapy for pediatric migraine.

Headache. 55: 1382-1396Power S.W. Kashikar-Zuck S.M. Allen J.R. et al.

Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents: A randomized clinical trial.

JAMA. 310: 2622-2630Kroner J.W. Hershey A.D. Kashikar-Zuck S.M. et al.

Cognitive Behavioral Therapy plus Amitriptyline for Children and Adolescents with Chronic Migraine Reduces Headache Days to ≤4 per Month.

Headache. 56: 711-716Stubberud A. Tronvik E. Olsen A. et al.

Biofeedback Treatment App for Pediatric Migraine: Development and Usability Study.

Headache. 60: 889-901Minen M.T. Adhikari S. Padikkala J. et al.

Smartphone-Delivered Progressive Muscle Relaxation for the Treatment of Migraine in Primary Care: A Randomized Controlled Trial.

Headache. 60: 2232-2246Szperka C.L. Gelfand A.A. Hershey A.D.

Patterns of Use of Peripheral Nerve Blocks and Trigger Point Injections for Pediatric Headache: Results of a Survey of the American Headache Society Pediatric and Adolescent Section.

Headache. 56: 1597-1607Gelfand A.A. Reider A.C. Goadsby P.J.

Outcomes of greater occipital nerve injections in pediatric patients with chronic primary headache disorders.

Pediatr Neurol. 50: 135-139Robbins M.S. Robertson C.E. Kaplan E. et al.

The Sphenopalatine Ganglion: Anatomy, Pathophysiology, and Therapeutic Targeting in Headache.

Headache. 56: 240-258Cady R. Saper J. Dexter K. et al.

A double-blind, placebo-controlled study of repetitive transnasal sphenopalatine ganglion blockade with Tx360® as acute treatment for chronic migraine.

Headache. 55: 101-116Binfalah M. Alghawi E. Shosha E. et al.

Sphenopalatine Ganglion Block for the Treatment of Acute Migraine Headache.

Pain Res Treat. 2018https://doi.org/10.1155/2018/2516953Mousa M.A. Aria D.J. Mousa A.A. et al.

Sphenopalatine ganglion nerve block for the treatment of migraine headaches in the pediatric population.

Pain Physician. 24: E111-E116Kouri M. Somaini M. Cárdenas V.H.G. et al.

Transnasal sphenopalatine ganglion block for the preventive treatment of chronic daily headache in adolescents.

Children. 8: 1-8

The Efficacy of Botulinum Toxin in Pediatric Chronic Migraine: A Literature Review.

J Child Neurol. 35: 844-851Goenka A. Yu S.G. George M. et al.

Is Botox right for me: When to assess the efficacy of the Botox injection for chronic migraine in pediatric population.

Neuropediatrics. https://doi.org/10.1055/A-1832-9168Ali S.S. Bragin I. Rende E. et al.

Further Evidence that Onabotulinum Toxin is a Viable Treatment Option for Pediatric Chronic Migraine Patients.

Cureus. 11https://doi.org/10.7759/CUREUS.4343Shah S. Calderon M.D. Crain N. et al.

Effectiveness of onabotulinumtoxinA (BOTOX) in pediatric patients experiencing migraines: a randomized, double-blinded, placebo-controlled crossover study in the pediatric pain population.

Reg Anesth Pain Med. 46: 41-48Goenka A. Grace Yu S. Chikkannaiah M. et al.

Generalized Anxiety Disorder: A Predictor for Poor Responsiveness to Botulinum Toxin Type A Therapy for Pediatric Migraine.

Pediatr Neurol. 130: 21-27